Jci_page_head_homepage_01 Jci_page_head_homepage_02
Karen Honey
Published in Volume 118, Issue 9
J Clin Invest. 2008; 118(9):2989–2989 doi:10.1172/JCI36994
Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 1
Plans for a large clinical trial of a candidate vaccine for HIV were recently cancelled by the NIAID.